Skip to content

The Multi-layer Seamless Capsule of Fecal Microbiota Transplantation for Autism Spectrum Disorder: a Single Arm Study

The Multi-layer Seamless Capsule of Fecal Microbiota Transplantation for Autism Spectrum Disorder: a Single Arm Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071379
Enrollment
Unknown
Registered
2023-05-12
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Intervention group:FMT-MLSC

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: (1)Aged 2 to 17 years, male or female; (2)Meeting the ASD diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) of the American Psychiatric Association; (3)Accompanied with diarrhea, constipation, abdominal distension and/or food allergy/intolerance for at least 6 months and above symptoms occurred in the last 3 months; (4)Informed consent was signed by the subjects and/or guardians, and clinical data and blood, saliva, urine and feces samples were collected throughout the clinical trial; (5)Able to swallow the multi-layer seamless capsules by themselves.

Exclusion criteria

Exclusion criteria: (1)The diagnosis was Reiter's syndrome; (2)Previous history of brain injury, cerebral palsy, encephalitis or other brain organic diseases; (3)Diagnosis of other mental diseases; (4)Diagnosis of intestinal organic diseases, such as congenital megacolon, intestinal obstruction, intussusception, inflammatory bowel disease and etc.; (5)There are pathological intestinal inflammatory changes, such as inflammatory bowel disease; (6)Severe obesity or severe malnutrition; (7)Using probiotics, antibiotics and other drugs affecting intestinal flora in a planned way within the last 3 months or in the following 6 months; (8)Have received FMT treatment in the last 12 months.

Design outcomes

Primary

MeasureTime frame
Autism Behavior Checklist;Childhood Autism Rating Scale;

Secondary

MeasureTime frame
Bristol Stool Form Scale;Gastrointestinal Symptom Rating Scale;Structure of gut microbiome;

Countries

China

Contacts

Public ContactChen Qiyi

Shanghai Tenth People's Hospital

qiyichen2011@163.com+86 158 9645 3859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026